JX Advanced Metals
5016
SoftBank
9434
Metaplanet
3350
4
Toyota Motor
7203
5
Mitsubishi Heavy Industries
7011
JP Stock MarketDetailed Quotes
4598 Delta-Fly Pharma
- 596
- +6+1.02%
20min DelayNot Open Mar 19 15:30 JST
5.80BMarket Cap-3.00P/E (Static)
612High589Low142.80KVolume589Open590Pre Close85.88MTurnover87552wk High1.83%Turnover Ratio9.73MShares44552wk Low-218.3EPS TTM4.65BFloat Cap5380Historical HighLossP/E (Static)7.80MShs Float445Historical Low-198.78EPS LYR3.90%Amplitude--Dividend TTM17.02P/B100Lot Size--Div YieldTTM
Delta-Fly Pharma News
Delta-Fly Pharma: Notice regarding clinical trial status of DFP-10917+VEN
Delta-Fly Pharma: 3Q financial results presentation materials for the fiscal year ending 2025/3 20250214
Delta-Fly Pharma: Summary of financial results for the 3rd quarter of the fiscal year ending March 31, 2025 [Japanese GAAP] (unconsolidated)
Delta-Fly Pharma: Change Report (Special Case Target Stock Certificates, etc.)
Delta-Fly Pharma: Change reports (stock certificates subject to special cases, etc.)
Delta-Fly Pharma: 2025 President's New Year's Greetings (Notice regarding progress of major development products)
Delta-Fly Pharma: Change reports (stock certificates subject to special cases, etc.)
Delta-Fly Pharma: Large holding reports (stock certificates subject to special cases, etc.)
Delta-Fly Pharma: change report
Delta-Fly Pharma: Notice regarding completion of exercise of the 8th Stock Acquisition Rights (Stock Acquisition Rights with Exercise Price Amendment Clauses) and monthly exercise status
Delta-Fly Pharma: Notice Concerning Mass Exercise of the 8th Stock Acquisition Rights (Stock Acquisition Rights with Exercise Price Amendment Clauses)
Delta-Fly Pharma: Notice regarding clinical trial status of DFP-10917+VEN+ and DFP-10917
Delta-Fly Pharma: Notice regarding the development status of DFP-17729
Delta-Fly Pharma: change report
Delta-Fly Pharma: Notice regarding the monthly exercise status of the 8th Stock Acquisition Rights (Stock Acquisition Rights with Exercise Price Amendment Clauses)
Delta-Fly Pharma: Notice Concerning Mass Exercise of the 8th Stock Acquisition Rights (Stock Acquisition Rights with Exercise Price Amendment Clauses)
Delta-Fly Pharma: Notice regarding the clinical phase 3 comparative trial of DFP-14323
Delta-Fly Pharma: Confirmatory letter.
Delta-Fly Pharma: Half Year Report - Term 15 (2024/04/01 - 2025/03/31)
Delta-Fly Pharma: Notice regarding responses to inquiries